DUBLIN–(BUSINESS WIRE)–The “Erbitux Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering.
The report predicts the global Erbitux market to grow at a CAGR of 15% around the forecast period from 2021-2027.
The report on the global Erbitux market provides qualitative and quantitative analysis for the period from 2019 to 2027. The study on Erbitux market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.
The report on Erbitux market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global Erbitux market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Erbitux market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- The growing demand for the treatment of metastatic colorectal cancer and head and neck cancer will drive market growth for Erbitux market
2) Restraints
- The side effects of the drug-like such as severe allergic reactions are expected to hamper its market growth.
3) Opportunities
- The development of biosimilars in the coming years will offer new opportunities in different parts of the world.
Company Profiles
- Merck
- Bristol-Myers Squibb
- Eli Lilly
- Manus Aktteva Biopharma LLP
- Hubei xinkang pharmaceutical chemical co.,ltd
- Array BioPharma Inc
- Wuhan Sunrise Technology Development Company Limited
- Chembest Research Laboratories Limited
- NKMax
- Pierre Fabre
Segment Covered
The Global Erbitux Market by Types
- 100 mg/50 ml Injection
- 200 mg/100 ml Injection
The Global Erbitux Market by Applications
- Head and Neck Cancer
- Metastatic Colorectal Cancer
The Global Erbitux Market by End User
- Hospital Pharmacy
- Retail Pharmacies
- Others
For more information about this report visit https://www.researchandmarkets.com/r/26fbrt
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900